Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Buys 74,286 Shares of Company Stock

by · The Markets Daily

Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd purchased 74,286 shares of Anteris Technologies Global stock in a transaction that occurred on Wednesday, September 30th. The stock was acquired at an average cost of $7.72 per share, with a total value of $573,487.92. Following the transaction, the insider owned 4,877,827 shares in the company, valued at $37,656,824.44. This trade represents a 1.55% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

  • On Thursday, October 1st, L1 Capital Pty Ltd acquired 322,940 shares of Anteris Technologies Global stock. The shares were acquired at an average price of $7.60 per share, for a total transaction of $2,454,344.00.
  • On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.83, for a total transaction of $68,874.00.
  • On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total transaction of $3,495,079.50.
  • On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total transaction of $2,291,780.40.
  • On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10.
  • On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
  • On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
  • On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.
  • On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.15, for a total value of $396,994.65.
  • On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total value of $1,250,260.20.

Anteris Technologies Global Stock Down 2.1%

NASDAQ AVR traded down $0.16 on Thursday, reaching $7.61. The company had a trading volume of 1,170,680 shares, compared to its average volume of 718,688. The company’s fifty day moving average is $8.51 and its 200 day moving average is $7.98. Anteris Technologies Global Corp. has a 52-week low of $3.30 and a 52-week high of $11.06. The stock has a market capitalization of $741.67 million, a P/E ratio of -3.90 and a beta of 1.87.

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). The firm had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.During the same period in the prior year, the firm earned ($0.58) earnings per share. On average, research analysts expect that Anteris Technologies Global Corp. will post -1.21 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on AVR shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Wednesday, August 26th. Cantor Fitzgerald reissued an “overweight” rating and set a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday, August 14th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Anteris Technologies Global presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

View Our Latest Stock Analysis on AVR

Institutional Investors Weigh In On Anteris Technologies Global

Hedge funds have recently modified their holdings of the stock. Nantahala Capital Management LLC bought a new position in Anteris Technologies Global during the second quarter valued at $33,325,850. One68 Global Capital LLC bought a new stake in shares of Anteris Technologies Global in the second quarter valued at $128,000. Bank of America Corp DE purchased a new position in shares of Anteris Technologies Global during the 2nd quarter valued at $1,907,000. AWM Investment Company Inc. purchased a new position in shares of Anteris Technologies Global during the 2nd quarter valued at $1,133,000. Finally, ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global during the 2nd quarter worth $30,979,000.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. is a medical device company focused on developing advanced technologies for structural heart disease. Its primary product candidate is the DurAVR transcatheter heart valve, designed to treat aortic valve stenosis through a minimally invasive transcatheter aortic valve replacement procedure.

The DurAVR valve is based on Anteris’ ADAPT tissue-engineering technology and is manufactured as a single-piece valve intended to replicate the performance and natural hemodynamics of a healthy human aortic valve.

See Also